Fundraising Fox
Saros Therapeutics
9 employees on LinkedIn · 1 known investors
Find your way into Saros Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Mike McMahon to introduce you to Rich Johnson
You →Mike · together at Duquesne University →Rich
Ask Jamie Chen to introduce you to Robert G. Petit
You →Jamie · together at Systems Oncology →Robert
Sign up to find every way you can get introduced to Saros Therapeutics
- Your email: who you already know at Saros Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Saros Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
The company develops cancer immunotherapy treatments. Based on the team composition and mission statement, it operates in the biotech and healthcare sectors.
Founders & leadership
Investors · 1
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1.2M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Saros Therapeutics do?
- The company develops cancer immunotherapy treatments. Based on the team composition and mission statement, it operates in the biotech and healthcare sectors.
- Who founded Saros Therapeutics?
- Saros Therapeutics was founded by Rich Johnson, Dominique Kendrick, Prof. James Moon, Prof. Yu Leo Lei, Robert Petit, Matthew Martin.
- Who are Saros Therapeutics's investors?
- Saros Therapeutics's investors include SmartHealth Catalyzer.